PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland
Abstract
Authors
J.A. Martikainen E.J. Soini J. Laine H. Åhman V. Postila P. Klemets